| Bioactivity | SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1]. |
| Name | SNX7 |
| CAS | 685097-43-2 |
| Formula | C15H14N2O |
| Molar Mass | 238.28 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129. |